Yeast metabolism may offer lessons on starving cancer cells

By Samantha Black, PhD, ScienceBoard editor in chief

January 21, 2020 -- Scientists may have found a new way to starve cancer cells by learning from growth regulation mechanisms employed by yeast. They found that the same metabolic mechanism used by yeast to respond to nutrient shortages is also employed by mammalian cells -- a finding that could lead to new cancer therapies, according to a new study published in Nature Metabolism on January 20.

A research team from Flinders University and St. Vincent's Institute of Medical Research in Australia investigated the link between metabolic systems, which are critical for the regulation of cell growth and proliferation. The team studied AMP-activated protein kinase (AMPK), which regulates cellular energy, and mammalian target of rapamycin (mTOR), which regulates cell growth through nutrient sensing. The dysregulation of these pathways is implicated in the pathogenesis of cancer, type 2 diabetes, and other human diseases.

"What is fascinating about this yeast is that it became evolutionarily distinct about 350 million years ago, so you could argue the discovery, that we subsequently confirmed occurs in mammals, is at least as ancient as that," said Jonathon Oakhill, PhD, an associate professor and the head of the Metabolic Signaling Laboratory at St Vincent's Institute.

The scientists generated yeast knock-in strains containing mutations to explore the effect of phosphorylation on highly conserved residues. They found that that mTOR complex 1 (mTORC1) directly downregulates AMPK signaling by phosphorylating the evolutionarily conserved residue S367 in the Ssp2, AMPK catalytic subunit, of fission yeast and in the AMPK α1 S347 and α2 S345 in the mammalian homologs.

"We have known for about 15 years that AMPK can 'put the brakes on' mTORC1, preventing cell proliferation," said Oakhill. "However, it was at this point that we discovered a mechanism whereby mTORC1 can reciprocally also inhibit AMPK and keep it in a suppressed state."

The yeast cells "became highly sensitive to nutrient shortages when we disrupted the ability of mTORC1 to inhibit AMPK," noted Janni Peterson, PhD, a professor from Flinders Centre for Innovation in Cancer. "The cells also divided at a smaller size, indicating disruption of normal cell growth regulation."

Janni Peterson, PhD, and colleagues looking at petri dish
"The findings provide a new opportunity for cancer treatment strategies aimed at suppressing cell proliferation in the nutrient-poor tumor microenvironment," said Janni Petersen, PhD (right). Image courtesy of Flinders University.

The researchers measured cancer growth rates in mammalian cells via α2 phosphorylation at S345 in the regulation of cell proliferation under nutrient stress. They achieved this by removing amino acids and energy (glucose) to mimic conditions in the tumor microenvironment.

"Surprisingly, we found that these combined stresses actually increased growth rates, which we determined was due to the cells entering a rogue 'survival' mode," said Peterson. "When in this mode, they feed upon themselves so that even in the absence of appropriate nutrients the cells continue to grow. Importantly, this transition to survival mode was lost when we again removed the ability of mTORC1 to inhibit AMPK."

The findings of this study may provide a new opportunity for researchers to explore the effect of treating cancer through suppression of cell proliferation within nutrient-poor tumor microenvironments.

Do you have a unique perspective on your research related to cancer biology or metabolism? Contact the editor today to learn more.


Copyright © 2020

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.